The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).
Recent reports of Tuberculosis, a disease long thought of as a ‘thing of the past’ have sparked many questions among the public – What is it? Will I catch it? How can I prevent it?
It’s among the most common infectious diseases, difficult to detect and is the leading cause of deafness in children. This relatively unknown disease is called Cytomegalovirus (CMV).